Filters

Bifidobacterium longum subsp. infantis N utilization substance protein B homolog (nusB)

Bifidobacterium longum subsp. infantis N utilization substance protein B homolog (nusB) size: 100ug 1591

Supplier MBS RECOMBINANT PROTEINS
Price 1591
Size 100ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long name infantis N utilization substance protein B homolog (nusB), Recombinant Bifidobacterium longum subsp
Alternative names N utilization substance protein B homolog, transcription antitermination factor NusB, NusB antitermination factor
Gene namenusB
Other gene names Protein NusB, nusB, BLIJ_0748
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, N utilization substance protein B homolog (nusB) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene target infantis N utilization substance protein B homolog (nusB), Bifidobacterium longum subsp
Short name infantis N utilization substance protein B homolog (nusB), Bifidobacterium longum subsp
Alternative name infantis N utilization substance protein B homolog (nusB), Bifidobacterium longum subsp
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter